Human heart failure is a complex syndrome and a primary cause of morbidity and mortality in the world. However, the molecular pathways involved in the remodelling process are poorly understood. In this study, we performed exhaustive global proteomic surveys of cardiac ventricle isolated from failing and non-failing human hearts, and determined the regulatory pathway to uncover the mechanism underlying heart failure. Two-dimensional gel electrophoresis (2-DE) coupled with tandem mass spectrometry was used to identify differentially expressed proteins in specimens from failing (n ϭ 9) and non-failing (n ϭ 6) human hearts. A total of 25 proteins with at least 1.5-fold change in the failing heart were identified; 15 proteins were up-regulated and 10 proteins were down-regulated. The altered proteins belong to three broad functional categories: (i) metabolic [e.g. NADH dehydrogenase (ubiquinone) 
Introduction
Heart failure, a complex syndrome that leads to left ventricular systolic and diastolic dysfunction, is one of the main causes of morbidity and mortality in the world [1] . Despite 
Materials and methods

Patient samples
Tissues for proteomic analysis were collected from the left ventricular free wall which was obtained from explanted hearts of transplant recipients (n ϭ 9) with a diagnosis of dilated cardiomyopathy (DCM, EF Յ 35%) and non-failing control hearts (n ϭ 6) which were obtained from unmatched donors whose hearts were not suitable to transplantation. The 14 
Whole protein extraction
Tissue was homogenized by a Polytron PT-MR2100 (Kinemetica AG, Switzerland) in lysis buffer (7M urea, 2M thiourea, 4% CHAPS, 2% IPG buffer pH 4-7 linear, 40 mM Tris, 65 mM DTT). Homogenates were immediately placed on ice to inhibit proteolysis, and then centrifuged at
Two-dimensional gel electrophoresis
2-DE was performed according to the manufacturer's instructions (GE
Real-time reverse transcriptase-polymerase chain reaction (RT-PCR)
Total RNA was extracted from tissues by using Trizol reagent (Invitrogen), and cDNA was synthesized with Superscript II (Invitrogen) in accordance with the manufacturer's instructions. Selected mRNAs (HSP27 and HSP20) were quantified with TaqMan quantitative RT-PCR. Primers for HSP20: 5Ј-CGTGGAGGTGCACGCG-3Ј, 3Ј-GCGACGGTGGAACTC GC-5Ј, probe: FAM-AGCGCCCGGATGAGCACG-BHQ1; Primers for HSP27: 5Ј-GATGAAGCTGT-CACTCGAGGC-3Ј, 3Ј-CCATCTCAGAGATATTGGATATGGT-5Ј, probe: FAM-
Statistical analysis
In this study, more than 1. (Fig. 2C) . The distribution and function of these expressed proteins provide a link to molecular components and pathways that may be involved in the development of heart failure progression. The findings suggest that major protein changes in human heart failure pathogenesis can be grouped into three main categories: proteins involved in mitochondria and energy production, cytoskeletal proteins and binding proteins. Therefore, the pathology of the failing heart is characterized by reduced mitochondrial activity, disruption of energy production and loss of cardiomyocytic structural integrity.
Results
Differential protein expression analysis of failing and non-failing human hearts
The network of proteomics
To characterize the functions associated with the detected proteins, the protein list was uploaded into the IPA software server and analysed using the Core Analysis module per the manufacturer's instructions (http://www.ingenuity.com). As seen in Figure 3 , the proteins are most significantly related to cardiovascular diseases and organism injury and abnormalities, which suggests that the proteins detected in this study is mostly regulators/effectors of the progression of heart failure.
As shown in Figure 4 , the proteins mentioned before constitute the main structure of the regulation network. They all participate in the process of heart failure connected by important modulators, such as NF-B, Myc and P38-MAPK, in respective pathways [6] [7] [8] . Besides, several metabolism disease pathways, including Growth Hormone and PRDX6, were also highlighted [9] . Meanwhile, functional modules related to cell differentiation and proliferation, as well as apoptosis were centred in the interaction network including only experimentally validated targets. Moreover, some important modulators in immune/inflammatory response, cardiovascular development or angiogenesis, such as TTR, ANGPT2 and FABP can also be found in the interaction map [10] [11] [12] . Therefore, the altered expression of those key proteins may cause the acceleration or deference of the heart failure process. (Fig. 6 ). (Fig. 8) .
Western blot analysis
Merging proteomics and gene expression signatures
Integration of proteomics with gene expression profiling would be more informative than either platform alone in capturing differentially involved gene networks between heart functional subtypes. Hierarchical cluster analysis of 741 significantly differentially expressed genes successfully segregates heart failure disease from healthy controls (Fig. 7). To identify a core set of functionally relevant genes/proteins, we explored the overlap of the differentially © 2011 The Authors Journal of Cellular and Molecular Medicine © 2011 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Discussion
The [16] [17] [18] . It could also resulted from the time course differences in transcription and pathological processes, the dysregulated proteins in failed heart may be expressed at prior stage, suggesting it will be ideally to detect mRNA expression profile at early stage of heart failure in the future study.
The proteins expressed in failing hearts were first investigated over a decade ago in a mouse model using two-dimensional polyacrylamide gel electrophoresis (2-D PAGE) [13] . Other researchers have shown that main proteins that exhibited changes in expression in mouse heart failure models belong to specific functional categories, including myocardial proteins, signal transduction proteins, metabolism-related proteins, transcriptional and translational proteins, growth and proliferation proteins and proteins with unknown function [14] [15] [16] . Although several studies have identified specific pathways that may be involved in heart failure [17] [18] , few have taken a global approach to identify key components of heart disease pathogenesis, especially using proteins extracted from the failing human heart. Through proteomic 
Mitochondrial and energy metabolism proteins
The proteins located within the mitochondria or involved in processes of energy metabolism play an important role in the heart's metabolic function. The main way that myocytes compensate for decreasing mitochondrial function is by increasing the expression of glycolysis-related proteins [19] . Therefore, high rates of myocardial energy production are required to maintain the constant demand of the working heart for adenosine triphosphate (ATP) and key enzymes involved in the Krebs cycle [20] .
A total of seven proteins involved in the tricarboxylic acid cycle and respiratory activities change. Pronounced changes in key enzymes that regulate oxidation processes have often been revealed in subunits of electron transport chain complexes [21, 22] studies of cardiac hypertrophy in non-failing hearts in pressureoverload-induced hypertrophy models [25] .
Cardiac muscle cell contraction
Our study indicates proteins involved in cell structure and muscle contraction also represent a large proportion of the expression proteins in the failing human heart. Seven cytoskeletal proteins with marked increases in expression are grouped in this category, including myosin light chain proteins, troponin I type 3 and transthyretin. Myosin light chain proteins are essential components in generating actin-based contractile force, and alterations in the expression of these proteins could affect myocardial contractility [26, 27] .
It has already been identified that the genetic ablation of the Nterminal myosin essential light chain extension induces reduced force per cross-sectional area of muscle and leads to age-dependent compensatory cardiac hypertrophy [28] . Specifically, changes in myosin light chain 2 protein expressions have been linked to contractile dysfunction in dilated cardiomyopathy [29] , ischaemia/reperfusion injury [30] and heart failure [31] 
Others
Our study investigates some highly expressed proteins that maintain both morphologic and functional integrity of cardiomyocytes and increase tolerance against various types of stress, including ␣B-crystallin, HSP27 and HSP20 [34] [35] [36] .
HSPs fulfil a wide range of functions, including cytoprotection and the intracellular assembly, folding and translocation of oligomeric proteins, and also represent a rapid response to altered redox states [37] . Failure to increase the levels of these high molecular HSPs may represent a loss of compensatory responsiveness in the setting of heart failure [38] . The highly expressed small HSPs (smHSPs) may exert effects on the left ventricular remodelling process that are different from those of high molecular HSPs, and it may be important to investigate the expression levels of smHSPs to better understand the pathogenesis of heart failure [39] . ␣B-crystallin is an smHSP structurally related to other smHSPs including ␣A-crystallin, HSP27, HSP20, HSP22, myotonic dystrophy protein kinase binding protein and HSPB3 [40] . ␣B-crystallin has strong anti-apoptotic properties and, when fully induced, is the most abundant smHSP in the heart and may constitute as much as 5% of total cardiac myocyte protein. It has been proposed that chaperoning by ␣B-crystallin can stabilize myofilament proteins through selective interactions with actin, titin, nebulette and the intermediate filaments desmin and vimentin [41] . With the compromise of ␣B-crystallin function, abnormal desmin forms aberrant aggregates and disrupts the integrity of the desmin network, which causes a reduction in cardiac function [42, 43] .
An interesting finding in our study is the down-regulation of BCL2A1 (often named bfl-1) in patients with heart failure. There is not much known about the role of BCL2A1 in cardiac function and the implication in heart failure. Like many members of BCL2 family, BCL2A1 contains both pro-and anti-apoptotic properties depending on its intracellular localization [44, 45] . In a mouse model that mimics the mitochondrial DNA mutation-induced dilated cardiomyopathy, it has been shown that BCL2A1 and HSP27 are up-regulated as a compensatory mechanism to protect against apoptosis [46] . Therefore, it may be possible that the low levels of BCL2A1 are associated with the increased cell death during the heart failure. More research needs to be done to fully understand the biological roles of BCL2A1 that influence the course and outcome of heart failure.
In this study, human heart tissues were used to find that major protein changes in heart failure pathogenesis can be grouped into proteins involved in mitochondria and energy production and cytoskeleton proteins. Further studies of these proteins and pathways during the end-stage heart failure are necessary to address their precise roles in the pathophysiology of heart failure and their potential as diagnostic tools or therapeutic targets. This study has raised numerous questions and opened several new avenues for the future study of this complex disease.
